SavedAdd your journal

Journals / Türk Kardiyoloji Derneği Arşivi / 2005 / Cilt: 33 - Sayı: 2

The physiopathology and treatment of in-stent restenosis

Stent-içi restenozun fizyopatolojisi ve tedavisi

Nurullah TÜZÜN
Abdullah DOĞAN
Ömer KOZAN
Pages
115–125
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This article revisits the pathophysiology and current therapeutic modalities of in-stent restenosis

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Percutaneous coronary intervention with stenting is an appropriate alternative to surgical revascularization in the management of coronary artery disease.
📊
Key Findings & Data:Brachytherapy and drug-eluting stents are current therapeutic options to reduce in-stent restenosis and decrease the probability of its occurrence, respectively.
💡
Conclusion & Impact:This article revisits the pathophysiology and current therapeutic modalities of in-stent restenosis
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Percutaneous coronary intervention with stenting is an appropriate alternative to surgical revascularization in the management of coronary artery disease. Despite new medications and techniques, in-stent restenosis still remains an unresolved problem. Brachytherapy and drug-eluting stents are current therapeutic options to reduce in-stent restenosis and decrease the probability of its occurrence, respectively. This article revisits the pathophysiology and current therapeutic modalities of in-stent restenosis

Özet

Koroner arter hastalığının tedavisinde, stent kullanılarak yapılan perkütan koroner girişim, cerrahi revaskülarizasyona iyi bir seçenektir. Bununla birlikte, medikal ve teknik yeniliklere rağmen, stent-içi restenoz henüz çözülmemiş bir sorundur. Stent-içi restenozu geriletmek için brakiterapi ve gelişme olasılığını azaltmak için ilaç kaplı stentler güncel tedavi seçenekleridir. Bu derlemede stent-içi restenozun fizyopatolojisi ve tedavi yöntemleri gözden geçirilmiştir.

🔖

Cite This Article

TÜZÜN, N., DOĞAN, A., KOZAN, Ö. (2022). The physiopathology and treatment of in-stent restenosis. Türk Kardiyoloji Derneği Arşivi, Cilt: 33 - Sayı: 2, 115–125. https://ajindex.com/articles/633759

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Lowe HC, Oesterle SN, Khachigian LM., Coronary instent restenosis: current status and future strategies. J Am Coll Cardiol 2002;39:183-93
  2. Rajagopal V, Rockson SG. Coronary restenosis: a review of mechanisms and management. Am J, Med 2003;l 15:547-53
  3. Bennett MR. In-stent stenosis: pathology and implications for the development of drug eluting stents. Heart 2003;89:218-24
  4. Ong AT, Aoki J, McFadden EP, Serruys PW. Classification and current treatment options of in-stent restenosis. Present status and future perspectives. Herz 2004;29:187-94
  5. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31
  6. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349:1315-23
  7. Pakala R, Willerson JT, Benedict CR. Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation. Circulation 1997;96:2280-6
  8. Moreno PR, Palacios IF, Leon MN, Rhodes J, Fuster V, Fallon JT. Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am J Cardiol 1999;84:462-6
  9. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, et al. Pathology of acute and chroniccoronary stenting in humans. Circulation 1999;99:44-52
  10. El-Omar MM, Dangas G, Iakovouul, Mehran R. Update on in-stent restenosis. Curr Interv Cardiol Rep 2001;3:296-305
  11. Cutlip DE, Chauhan MS, Bairn DS, Ho KK, Popma JJ, Carrozza JP, et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol 2002;40:2082-9
  12. Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998;32:584-9
  13. Mehran R, Dangas G, Abizaid AS, Mijitz GS, Lansky AJ, Satler LF, et al. Angiographic patterns of in-stent restenosis: classification and implications for long- term outcome. Circulation 1999;100:1872-8
  14. Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K, et al. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation 200